Mesenchymal stem cells (MSCs) are multipotent non-hematopoietic cells capable of differentiating into hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has recently exhibited profound therapeutic activity in preclinical tumor test. A research group in China investigated the induction of hepatic differentiation of mouse bone marrow MSCs (mBM-MSCs) by VPA. Direct evidences have been shown that the usefulness of VPA in the trans-differentiation of mBM-MSCs into hepatocytes both in vitro and in vivo.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Americans find doing their own taxes simpler than improving diet and health
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Tinnitus Severity Is Reduced with Reduction of Depressive Mood – a Prospective Population Study in Sweden
- Deep Brain Stimulation of Nucleus Accumbens Region in Alcoholism Affects Reward Processing
- The Role of Attention in Ambiguous Reversals of Structure-From-Motion